Thursday, October 07, 2021 4:57:38 PM
i guess this is the new proactive video program. personally, i'm going to really miss christine corrado....
i'm most curious to know how long this suit against amarex will delay the BLA. i've never seen a fast lawsuit - and to the extent both sides dig in, it could last a long time. question is - is the BLA held up until we force them to give us the data? i sure hope not.
Brazil remains a big focus too - but i think the market for COVID therapeutics will shrink rapidly. Once kids are vaccinated in developed countries, it will diminish greatly. And Merck's therapeutic is big - and likely only the first of many therapeutics coming from big pharma in pill form which can be shipped in the millions. Adding all of it up, and there will be a lot less people getting really sick with COVID. In a couple of years, it may be exceedingly rare - and this is likely why all of the therapeutic companies sold off so much after the Merck news.
let's get some good news about the Brazil enrollment - with this Amarex nonsense, that seems to be the only shot on goal we have at this point. the fact that we haven't heard anything makes me wonder about the speed of enrollment - hopefully i'm wrong, and we'll get an update tomorrow saying that its going incredibly well.
i'm most curious to know how long this suit against amarex will delay the BLA. i've never seen a fast lawsuit - and to the extent both sides dig in, it could last a long time. question is - is the BLA held up until we force them to give us the data? i sure hope not.
Brazil remains a big focus too - but i think the market for COVID therapeutics will shrink rapidly. Once kids are vaccinated in developed countries, it will diminish greatly. And Merck's therapeutic is big - and likely only the first of many therapeutics coming from big pharma in pill form which can be shipped in the millions. Adding all of it up, and there will be a lot less people getting really sick with COVID. In a couple of years, it may be exceedingly rare - and this is likely why all of the therapeutic companies sold off so much after the Merck news.
let's get some good news about the Brazil enrollment - with this Amarex nonsense, that seems to be the only shot on goal we have at this point. the fact that we haven't heard anything makes me wonder about the speed of enrollment - hopefully i'm wrong, and we'll get an update tomorrow saying that its going incredibly well.
Recent CYDY News
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
